Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1995 2
1996 2
1998 4
1999 1
2000 3
2001 1
2002 1
2003 4
2004 3
2005 2
2006 4
2007 8
2008 6
2009 5
2010 4
2011 5
2012 5
2013 3
2014 3
2015 5
2016 7
2017 8
2018 2
2019 6
2020 10
2021 11
2022 5
2023 9
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for podglajen i
Search for Podglagen I instead (2 results)
Answer to January 2017 Photo Quiz.
Compain F, Rossi B, Richaud C, Guerot E, Rostane H, Jarraud S, Podglajen I. Compain F, et al. Among authors: podglajen i. J Clin Microbiol. 2016 Dec 28;55(1):349-350. doi: 10.1128/JCM.03512-14. Print 2017 Jan. J Clin Microbiol. 2016. PMID: 28031452 Free PMC article. No abstract available.
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Compain F, Rossi B, Richaud C, Guerot E, Rostane H, Jarraud S, Podglajen I. Compain F, et al. Among authors: podglajen i. J Clin Microbiol. 2016 Dec 28;55(1):1-2. doi: 10.1128/JCM.masthead.55-1. Print 2017 Jan. J Clin Microbiol. 2016. PMID: 28031443 Free PMC article. No abstract available.
Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates.
Petillon C, Ulutuipalelei M, Beyrouthy R, Proust S, Aissa N, Bret L, Brieu N, Carricajo A, Cattoir V, Dauwalder O, Degand N, Dortet L, Doucet-Populaire F, Dubois V, Grillon A, Guérin F, Lanotte P, Lemaitre N, Leyssene D, Neuwirth C, Patry I, Ploy MC, Podglajen I, Recule C, Rouis K, Réseau O, Robert J, Bonnet R, Robin F. Petillon C, et al. Among authors: podglajen i. Diagn Microbiol Infect Dis. 2025 Nov;113(3):117011. doi: 10.1016/j.diagmicrobio.2025.117011. Epub 2025 Jul 15. Diagn Microbiol Infect Dis. 2025. PMID: 40683213
Modes and modulations of antibiotic resistance gene expression.
Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. Depardieu F, et al. Among authors: podglajen i. Clin Microbiol Rev. 2007 Jan;20(1):79-114. doi: 10.1128/CMR.00015-06. Clin Microbiol Rev. 2007. PMID: 17223624 Free PMC article. Review.
Carbapenemase-producing bacteria in patients hospitalized abroad, France.
Compain F, Decré D, Frazier I, Ramahefasolo A, Lavollay M, Carbonnelle E, Rostane H, Tackin A, Berger-Carbonne A, Podglajen I. Compain F, et al. Among authors: podglajen i. Emerg Infect Dis. 2014 Jul;20(7):1246-8. doi: 10.3201/eid2007.131638. Emerg Infect Dis. 2014. PMID: 24963645 Free PMC article. No abstract available.
Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
Grohs P, Vilfaillot A, Zahar JR, Barbut F, Frange P, Casetta A, Moulin V, Lawrence C, Baune P, Bourgeois C, Bouffier A, Laussucq C, Sienzonit L, Picard S, Podglajen I, Kassis-Chikhani N. Grohs P, et al. Among authors: podglajen i. J Antimicrob Chemother. 2022 Sep 30;77(10):2667-2678. doi: 10.1093/jac/dkac289. J Antimicrob Chemother. 2022. PMID: 36031727
Evaluation of a novel automated pre-cleaning method for endoscopy.
Mevel F, Rahmi G, Sornet A, Hillion AM, Ronceray C, Cellier C, Podglajen I, Kassis-Chikhani N. Mevel F, et al. Among authors: podglajen i. J Hosp Infect. 2025 Sep;163:82-86. doi: 10.1016/j.jhin.2025.06.011. Epub 2025 Jun 28. J Hosp Infect. 2025. PMID: 40588010 No abstract available.
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C, Gordien E, Rameix-Welti MA, Gault E, Moreau F, Fourati S, Challine D, Pawlotsky JM, Houhou-Fidouh N, Damond F, Mackiewicz V, Charpentier C, Méritet JF, Rozenberg F, Podglajen I, Marot S, Petit H, Burrel S, Akhavan S, Leruez-Ville M, Avettand-Fenoel V, Fourgeaud J, Guilleminot T, Gardiennet E, Bonacorsi S, Carol A, Carcelain G, Villemonteix J, Boukli N, Gozlan J, Morand-Joubert L, Legoff J, Delaugerre C, Chaix ML, Roque-Afonso AM, Dortet L, Naas T, Ronat JB, Lepape S, Marcelin AG, Descamps D. Vauloup-Fellous C, et al. Among authors: podglajen i. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2235-2241. doi: 10.1007/s10096-021-04232-3. Epub 2021 Mar 29. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33782783 Free PMC article.
114 results